Biocon to divest stake in AxiCorpIllustrative image – not actual.

Biocon is likely to offload its entire stake in AxiCorp GmbH back to the promoters of the German distribution company.

The company is likely to sell its 78 per cent stake in AxiCorp. The mutually beneficial transaction will be completed by June 2011 for Euro 42 million (approx Rs 276 crore).

Biocon was finding it irrelevant to remain with AxiCorp as it was a low margin operative under Germany's stern regulations and a mandatory 16 per cent rebate on pharma products.

← All latest storiesBack to top →